(Q408163)

anagrelide (English)

3 October 2016

C₁₀H₇Cl₂N₃O

1 reference

anagrelide (English)

20 November 2016

C1C2=C(C=CC(=C2Cl)Cl)NC3=NC(=O)CN31

1 reference

World Health Organisation international non-proprietary name

anagrelide (English)

20 November 2016

1 reference

14 February 2018

anagrelide (English)

1 reference

anagrelide (English)

medical condition treated

3 October 2016

1 reference

13 December 2016

1 reference

myeloproliferative disorders

13 December 2016

1 reference

13 December 2016

essential thrombocytosis

1 reference

Drug Indications Extracted from FAERS

2 October 2018

14 March 1997

Food and Drug Administration

1 reference

Inxight: Drugs Database

https://drugs.ncats.io/drug/K9X45X0051

2 November 2018

reference URL

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb960074-99c1-4a73-941f-f0644a7ec219

significant drug interaction

halofantrine

1 reference

High-priority drug–drug interactions for use in electronic health records

amiodarone

1 reference

High-priority drug–drug interactions for use in electronic health records

arsenic trioxide

1 reference

High-priority drug–drug interactions for use in electronic health records

astemizole

1 reference

High-priority drug–drug interactions for use in electronic health records

azithromycin

1 reference

High-priority drug–drug interactions for use in electronic health records

bepridil

1 reference

High-priority drug–drug interactions for use in electronic health records

chloroquine

1 reference

High-priority drug–drug interactions for use in electronic health records

chlorpromazine

1 reference

High-priority drug–drug interactions for use in electronic health records

cisapride

1 reference

High-priority drug–drug interactions for use in electronic health records

(RS)-citalopram

1 reference

High-priority drug–drug interactions for use in electronic health records

clarithromycin

1 reference

High-priority drug–drug interactions for use in electronic health records

cocaine

1 reference

High-priority drug–drug interactions for use in electronic health records

disopyramide

1 reference

High-priority drug–drug interactions for use in electronic health records

dofetilide

1 reference

High-priority drug–drug interactions for use in electronic health records

domperidone

1 reference

High-priority drug–drug interactions for use in electronic health records

dronedarone

1 reference

High-priority drug–drug interactions for use in electronic health records

droperidol

1 reference

High-priority drug–drug interactions for use in electronic health records

erythromycin

1 reference

High-priority drug–drug interactions for use in electronic health records

escitalopram

1 reference

High-priority drug–drug interactions for use in electronic health records

flecainide

1 reference

High-priority drug–drug interactions for use in electronic health records

haloperidol

1 reference

High-priority drug–drug interactions for use in electronic health records

ibutilide

1 reference

High-priority drug–drug interactions for use in electronic health records

mesoridazine

1 reference

High-priority drug–drug interactions for use in electronic health records

(RS)-methadone

1 reference

High-priority drug–drug interactions for use in electronic health records

moxifloxacin

1 reference

High-priority drug–drug interactions for use in electronic health records

ondansetron

1 reference

High-priority drug–drug interactions for use in electronic health records

pentamidine

1 reference

High-priority drug–drug interactions for use in electronic health records

pimozide

1 reference

High-priority drug–drug interactions for use in electronic health records

probucol

1 reference

High-priority drug–drug interactions for use in electronic health records

procainamide

1 reference

High-priority drug–drug interactions for use in electronic health records

quinidine

1 reference

High-priority drug–drug interactions for use in electronic health records

sevoflurane

1 reference

High-priority drug–drug interactions for use in electronic health records

sotalol

1 reference

High-priority drug–drug interactions for use in electronic health records

sparfloxacin

1 reference

High-priority drug–drug interactions for use in electronic health records

(RS)-sulpiride

1 reference

High-priority drug–drug interactions for use in electronic health records

terfenadine

1 reference

High-priority drug–drug interactions for use in electronic health records

thioridazine

1 reference

High-priority drug–drug interactions for use in electronic health records

amiodarone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

arsenic trioxide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

disopyramide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

toremifene

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sotalol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

erythromycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dronedarone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eribulin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vandetanib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

crizotinib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

droperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

haloperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zuclopenthixol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxifloxacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

iloprost

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aspirin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clopidogrel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eptifibatide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tirofiban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

abciximab

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prasugrel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ticagrelor

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pentamidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

domperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amiodarone

torsades de pointes

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

torsades de pointes

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7114

Australian pregnancy category B3

17 August 2016

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category E*

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Anagrelide

last update

5 July 2017

subject has role

phosphodiesterase inhibitor

1 reference

5 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

C021139

platelet aggregation inhibitors

15 March 2018

1 reference

InChI=1S/C10H7Cl2N3O/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7/h1-2H,3-4H2,(H,13,14,16)

Medical Subject Headings

15 March 2018

Anagrelide

0 references

Identifiers

InChI

1 reference

anagrelide (English)

20 November 2016

2 references

anagrelide (English)

20 November 2016

ChEBI release 2020-09-01

CAS Registry Number

68475-42-3

2 references

anagrelide (English)

20 November 2016

https://commonchemistry.cas.org/detail?cas_rn=68475-42-3

8 April 2021

1 reference

Anagrelide (English)

20 November 2016

1 reference

anagrelide (English)

20 November 2016

1 reference

Reaxys registry number

619582

1 reference

anagrelide (English)

3 October 2016

mapping relation type

2 references

ANAGRELIDE (English)

20 November 2016

International Chemical Identifier

InChI

InChI=1S/C10H7Cl2N3O/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7/h1-2H,3-4H2,(H,13,14,16)

1 reference

ANAGRELIDE (English)

20 November 2016

2 references

inferred from InChIKey

SCHEMBL318594

2 references

based on heuristic

inferred from InChIKey

HSDB ID

7325

1 reference

Hazardous Substances Data Bank

28 October 2019

ANAGRELIDE (English)

10 May 2021

0 references

DSSTOX compound identifier

DTXCID6028280

0 references

LiverTox ID

Anagrelide

0 references

ECHA Substance Infocard ID

0 references

1 reference

Guide to Pharmacology Ligand ID

Anagrelide (English)

publication date

17 November 2015

7114

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7114

anagrelide (English)

20 November 2016

anagrelide

1 reference

Medical Subject Headings

14 March 2018

1 reference

anagrelide (English)

20 November 2016

1 reference

Human Metabolome Database ID

HMDB0014406

2 references

based on heuristic

inferred from InChIKey

2 references

anagrelide (English)

20 November 2016

MedlinePlus drug identifier

0 references

1 reference

anagrelide (English)

20 November 2016

0 references

1 reference

https://docs.openalex.org/download-snapshot/snapshot-data-format

anagrelide (English)

3 October 2016

1 reference

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

Römpp online ID

RD-01-04925

1 reference

imported from Wikimedia project

1 reference